公司资料
iSpecimen 股价、新闻与催化剂
- 股票代码:
- ISPC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.14 USD (-3.39%)
收盘价
最后更新: 2026年10月1日
4.41M USD
市值
股价为何变动
截至 2026年10月1日，ISPC 下跌 3.39%，收于 $1.14。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.
所在地与行业分类
iSpecimen is headquartered in the United States and listed on NASDAQ. It sits in biotech infrastructure and research services.
商业模式特征
The business depends on research demand, platform adoption, and the ability to connect buyers and sample providers efficiently. Investors track revenue growth, customer acquisition, and the health of research spending.
生物医药行业定位
iSpecimen belongs in the infrastructure layer of the biotech ecosystem. It is not a drug developer, but it helps enable translational research and discovery.
未来催化剂
- iSpecimen’s catalysts are biospecimen marketplace growth and research-customer adoption. The business improves when the platform becomes more embedded in sourcing workflows.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。